Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K (AMENDMENT NO. 1) - EyePoint Pharmaceuticals, Inc. | d273854d10ka.htm |
| EX-10.13 - AMENDED AND RESTATED COLLABORATIVE RESEARCH AND LICENSE AGREEMENT - EyePoint Pharmaceuticals, Inc. | d273854dex1013.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - EyePoint Pharmaceuticals, Inc. | d273854dex312.htm |
Exhibit 31.1
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
CERTIFICATIONS
I, Paul Ashton, certify that:
| 1. | I have reviewed this Annual Report on Form 10-K/A (Amendment No. 1) of PSIVIDA CORP.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
Date: December 27, 2011
| /S/ PAUL ASHTON | ||
| Name: | Paul Ashton | |
| Title: | President and Chief Executive Officer (Principal Executive Officer) | |